HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons.

Abstract
Clinical efficacy of norfloxacin for treatment of traveler's diarrhea in 106 Finnish tourists vacationing in Morocco was evaluated during two different seasons. When the criteria for diagnosis of traveler's diarrhea were fulfilled, norfloxacin (400 mg) or a placebo was given orally, twice daily for 3 days. All symptoms and signs subsided sooner in the norfloxacin group. The clearest difference was observed in the duration of diarrhea: 1.2 days in the norfloxacin group vs. 3.3 days in the placebo group (P < .001). The duration of diarrhea due to particular species was as follows for the two groups: in cases due to Salmonella enterica, 1.1 vs 4.1 days (P < .01); in cases due to Campylobacter jejuni, 1.8 vs. 5.0 days (P < .01); and in cases due to enterotoxigenic Escherichia coli, 1.0 day vs. 3.1 days (P < .01). The rate of full recovery during administration of norfloxacin or a placebo was also greater among the norfloxacin recipients: 84% vs. 47% (P < .001). No significant adverse effects were reported. Norfloxacin proved to be safe and effective in therapy for traveler's diarrhea.
AuthorsL Mattila, H Peltola, A Siitonen, H Kyrönseppä, I Simula, M Kataja
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America (Clin Infect Dis) Vol. 17 Issue 4 Pg. 779-82 (Oct 1993) ISSN: 1058-4838 [Print] United States
PMID8268363 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Norfloxacin
Topics
  • Adolescent
  • Adult
  • Aeromonas (drug effects, isolation & purification)
  • Aged
  • Campylobacter jejuni (drug effects, isolation & purification)
  • Diarrhea (drug therapy, microbiology)
  • Double-Blind Method
  • Escherichia coli (drug effects, isolation & purification)
  • Female
  • Finland
  • Humans
  • Male
  • Middle Aged
  • Morocco
  • Norfloxacin (therapeutic use)
  • Rotavirus (isolation & purification)
  • Salmonella (drug effects, isolation & purification)
  • Seasons
  • Shigella (isolation & purification)
  • Travel

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: